Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
18.6%
% of FHLC's 349 holdings also in IXJ
53.6%
% of IXJ's 113 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 9.6% | 9.6% |
|
UNITEDHEALTH GROUP INC | 7.3% | 6.0% | 6.0% |
|
JOHNSON & JOHNSON | 6.4% | 5.5% | 5.5% |
|
ABBVIE INC | 6.1% | 4.4% | 4.4% |
|
ABBOTT LABORATORIES | 3.8% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to IXJ
|
ELI LILLY & CO | 1.7% |
|
ABBVIE INC | 1.7% |
|
UNITEDHEALTH GROUP INC | 1.2% |
|
MERCK & CO. INC. | 1.0% |
|
JOHNSON & JOHNSON | 0.9% |
|
THERMO FISHER SCIENTIFIC INC | 0.9% |
|
AMGEN INC | 0.6% |
|
PFIZER INC | 0.6% |
|
VEEVA SYSTEMS INC-CLASS A | 0.6% |
|
BRISTOL-MYERS SQUIBB CO | 0.5% |
FHLC Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -3.2% |
|
NOVARTIS AG | -3.2% |
 |
ASTRAZENECA PLC | -3.0% |
 |
NOVO NORDISK A/S-B | -2.9% |
 |
SANOFI-AVENTIS | -1.6% |
|
ESSILOR INTERNATIONAL | -1.2% |
 |
CSL LIMITED | -1.1% |
|
GSK PLC | -1.1% |
|
LONZA GROUP AG-REG | -0.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |